Symptoms typically spike during dose escalation, and standard titration often follows 0.25 mg once weekly for weeks 1 to 4, then 0.5 mg weekly for weeks 5 to 8, with many patients reporting gradual improvement after the initial escalation phase
The PlexusDx Precision Peptide Genetic Test analyzes key variantsincluding GIPR rs1800437, GLP1R rs6923761, and MC4R rs17782313to identify which patients may have stronger or weaker receptor sensitivity to GLP-1 signaling
Hydration benefits: Pregnant skin loses moisture 25% faster than usual, making hydrating treatments particularly effective for improving appearance without invasive procedures
The FDA labeling documents gastrointestinal adverse effects broadlyincluding nausea (occurring in 1544% of patients depending on dose and indication), vomiting, diarrhea, abdominal pain, and constipation